ARTICLES
-
-
Year
-
-
- Practices
-
Chinese Mainland Capital MarketsHong Kong & Overseas Capital MarketsInvestment/M&A & Corporate GovernanceCross-border Investment/M&AConstruction & Project DevelopmentFinancingDebt Restructuring & Non-performing AssetsTaxation & Wealth PlanningPrivate Equity & Investment FundsFinancial Products & TrustsLitigation & ArbitrationCorporate & Commercial CrimeBankruptcy, Insolvency & ReorganizationShippingCompliance & InvestigationAntitrust & CompetitionTrade Compliance & Trade RemediesCustoms & Import/ExportLabor & EmploymentHealth, Safety & Environmental ProtectionIP Licensing & EnforcementTrademark ProsecutionPatent ProsecutionCybersecurity & Data Protection
-
- Industries
-
Real EstateUrban InfrastructureTransportation & LogisticsTourism & HospitalityEnergy & PowerMining & Natural ResourcesBanking & Financial ServicesInsuranceFinancial Innovation & FintechTelecommunications & InternetInformation & Intelligence TechnologyHealthcarePharmaceuticals & Life SciencesEducation & TrainingMedia-Sports & EntertainmentNational Defense & Military IndustryRetail & Consumer ProductsIndustry & ManufacturingAgriculture & Food
-
- Latest
- Most relevant
-
-
2025-01-03
Trade Legal Due Diligence for Foreign Investment in China
Trade compliance risks, especially US export controls and sanctions, are top priority in due diligence for investment.
-
2024-12-26
Overseas Listed Companies’ Equity Incentives for Chinese Staff
Essential considerations for foreign-listed companies offering equity incentives to their employees in China.
-
2024-12-17
Updated Judicial Interpretations for Antitrust Disputes
This article highlights the SPC's new judicial interpretations on antitrust disputes.
-
2024-12-16
Key Considerations for International Buyers to Source from China
Key legal considerations for international buyers sourcing from China to minimize disputes and enhance protection.
-
2024-12-09
Key Takeaways: Picking Local Delegates in China for Drug MAHs
Key considerations for selecting and managing Local Delegates by foreign drug MAHs.